Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$17.4M | -$28.6M | -$43.6M | -$50.7M | -$54.0M | -$47.8M |
| Net income | -$7.84M | -$11.7M | -$21.4M | -$25.8M | -$34.0M | -$23.5M |
| EPS (diluted) | -$23.76 | -$3.13 | -$0.91 | -$0.86 | -$0.86 | -$0.32 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.43M | -$3.63M | -$18.5M | -$16.0M | -$28.5M | -$24.6M |
| Capital expenditures | $10.0K | $27.0K | $171K | $147K | $4.00K | — |
| Free cash flow | -$3.44M | -$3.66M | -$18.7M | -$16.2M | -$28.5M | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.19M | $54.7M | $41.6M | $29.9M | $25.0M | $36.8M |
| Total assets | $7.12M | $59.1M | $50.4M | $35.2M | $30.2M | $48.4M |
| Total liabilities | $19.9M | $7.86M | $10.2M | $10.7M | $11.5M | $14.1M |
| Shareholders' equity | -$68.2M | $51.3M | $40.2M | $24.5M | $18.8M | $34.3M |
| Retained earnings | -$68.2M | -$94.0M | -$115M | -$141M | -$175M | -$199M |
| Shares (wtd avg diluted) | 508K | 5.19M | 23.6M | 30.0M | 39.7M | 72.8M |
Every figure is extracted from COGNITION THERAPEUTICS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.